Germany Cannabis Consultants for BfArM Licenses and Higher Yields
Germany cannabis consulting starts with a yes for medical cannabis: BfArM grants MedCanG licenses on application, while no adult-use shop license exists. Investors need the license, AMG and GMP approvals and fee plan; licensed growers need yield, drying-room and margin fixes. Our records: 58+ licenses secured.
A Decade of Harvesting Success - Trusted by Cannabis Operators Worldwide
Three German Filing Dates to Note
Updated: 10/9/2026. Since April 1, 2024, Germany has run two cannabis laws. The Medical Cannabis Act (MedCanG) requires a license from BfArM, the Federal Institute for Drugs and Medical Devices, for anyone who grows, makes, trades in, imports, exports, sells or acquires medical cannabis (MedCanG § 4), with narrow exemptions such as pharmacies, and only pharmacies may dispense it to patients, on prescription. The Consumer Cannabis Act (KCanG) allows adult possession, home growing and non-profit cultivation clubs licensed by each state’s authority; it creates no commercial store license, and its research licenses go to BLE, the Federal Office for Agriculture and Food, not BfArM.
Every BfArM license holder files its yearly report by January 31, and licensed clubs report their grown, passed-on and destroyed quantities and year-end stock to their state authority by the same date. By April 30, state authorities pass the previous year’s club data to the body the health ministry names, and the full independent evaluation of the KCanG is due by April 1, 2028 (KCanG § 43).
Meet Catalyst BC's Founders
-
Leif Olsen
Chief Executive Officer
-
Michael Williamson
Chief Operating Officer
-
Ian Miller
Executive Chair
Our partners bring multi-faceted expertise across business strategy, licensing, facility development, finance, and commercial operations. That breadth is complemented by subject matter experts across the wider Catalyst BC team, allowing us to bring the right combination of experience to each client and project. The result is bespoke, collaborative support shaped around your business, priorities, and goals - with the right expertise brought to the table when it matters most.
As Featured In:
What a Germany Cannabis Consultant Adds Beyond the BfArM Forms
BfArM decides license files and supervises cultivation; it does not plan your company, your drying rooms or your supply contracts. A Germany cannabis consultant works for the owner, from the responsible-person setup and room plans that pass review to the records and variety list that keep a license current.
Investing in German Medical Cannabis: What You Can Own and What It Costs
No German license lets you open an adult-use cannabis shop, so this section covers the routes a BfArM license opens: growing, manufacturing, domestic wholesale, or import and export. Each route needs a BfArM license application naming a responsible person with proven expertise, and a certificate of good conduct (Führungszeugnis) for the applicant and each responsible person (MedCanG § 7). Growers also need a manufacturing authorization under the Medicines Act (AMG) and a GMP (good manufacturing practice) certificate from their state authority for drying and later steps, and a separate trade license if they import cuttings or trade flowers (BfArM cultivation guidance).
Fees are modest but multiply: BfArM charges per cannabis variety and per site, so a large strain list costs more than the building plan suggests. Demand is the bigger variable: every sale to a patient runs through a pharmacy on prescription, and a law in force since July 29, 2026 ended statutory health insurance payment for cannabis flowers, unprocessed or in preparations, so in our view a Germany cannabis business plan should price extracts and self-pay demand separately.
For investors: structure and site screening through cannabis business strategy, fee and margin models through cannabis financial planning, the BfArM file and Germany cannabis license application through cannabis license application support, and cannabis startup support from the first room plan to the first reported harvest.
Already Licensed in Germany: Drying Rooms, Variety Lists and Margins After July 2026
A BfArM license fixes the site, the activities and each variety you may handle, so adding a strain needs BfArM’s approval, as a new license at the full per-variety fee or as an amendment (MedCanG § 8). Your records must show, per site and per variety, every receipt and dispatch with the resulting stock, the foreign counterparty for imports and exports, the growing area and sowing date, and for manufacturers the cannabis used and the yield; they are kept three years (MedCanG § 16).
Domestic flower competes with imports, which reached about 80 metric tons in the first half of 2025, up from about 19 metric tons a year earlier, while statutory insurance prescriptions grew by a single-digit percentage (federal health ministry amendment FAQ). In our view, margin therefore depends on yield per square meter and batches that pass quality release, and Germany cannabis facility design starts with the drying and processing rooms the GMP certificate covers, not with adding canopy.
For licensed German growers we offer Germany cannabis facility design with HVACD (heating, ventilation, air conditioning and dehumidification) sized to the GMP drying plan, controlled environment agriculture targets by room, cannabis vertical farming to add yield in an existing building, operational optimization of batch records and labor and, when prices fall below cost, a cannabis turnaround plan. Michael Williamson, our Chief Operating Officer and a co-founder, is GAP (good agricultural practices) certified from Cornell University and has designed and consulted on over 7 million square feet of indoor, greenhouse and outdoor cultivation (company-reported).
Our Germany record and team: our records list no Germany client, and we have no Germany office. We work on-site and remotely. Leif Olsen, our Chief Executive Officer and a co-founder, leads our licensing work, and Ian Miller, our Executive Chair and a co-founder, holds a Master of Science in Building Construction from the University of Florida. The same team runs Catalyst BC’s international cannabis consulting practice.
A word against our own interest: BfArM publishes its application notes and forms, and a company with an experienced responsible person and GMP staff can file without us. To talk through a German plan, contact us or call +1 303-305-3787.
Investing in Germany cannabis
- Cannabis Business Strategy ConsultingCompany structure and site screening
- Cannabis Financial Planning & ModelingPer-variety fees and margin models
- Cannabis Licensing & Application SupportThe BfArM license file
- Cannabis Startup SupportRoom plan to first reported harvest
Already licensed in Germany
- Cannabis Facility Design & HVAC / HVACD EngineeringHVACD sized to the GMP drying plan
- Cannabis Controlled Environment Agriculture (CEA)Room targets for releasable batches
- Cannabis Vertical Farming ConsultingMore yield in the same building
- Cannabis Operational OptimizationBatch records, labor and reporting
- Cannabis Business Turnaround & Operational RecoveryCosts back under market prices
Compliant Harvests
Square Feet of Cultivation, Production, and Retail Facilities Designed
Licenses Secured
Applying in Germany Today: Medical Licenses Yes, Adult-Use Shops No
Yes, for medical cannabis. BfArM grants MedCanG licenses on application, for the specific site and the scope of activity requested, and issues time-limited licenses for time-limited projects (BfArM license page). Companies no longer need to win a Europe-wide tender to grow medical cannabis, and growers may market and distribute their own harvest (federal health ministry Cannabis Act FAQ).
No, for adult-use sales. The KCanG lets licensed clubs pass cannabis only to their own members, and BLE, which licenses consumer-cannabis research, states that under current law it sees no way to license regional, time-limited cannabis model projects (BLE consumer cannabis page).
Research with consumer cannabis is the narrow exception. Since December 2024, companies, associations and individuals as well as universities can ask BLE for a research license, which the KCanG allows only in exceptional cases and only to adults. Applications have no deadline, and since July 1, 2026 BLE charges time-based fees for them.
Which German authority grants which approval
| Approval | Authority | Legal basis |
|---|---|---|
| License to grow, make, trade, import or export medical cannabis | BfArM | MedCanG § 4 |
| Approval for each individual import or export | BfArM | MedCanG § 12 |
| Manufacturing authorization for medicines (including drying of medical flowers) | State authority where the site lies | AMG § 13 |
| Wholesale authorization for medicines | State authority where the site lies | AMG § 52a |
| Import authorization for medicines from outside the EU and EEA | State authority where the site lies | AMG § 72 |
| License for a cultivation club | Authority named by each state | KCanG §§ 11 and 33 |
| License to handle consumer cannabis for research | BLE, the Federal Office for Agriculture and Food | KCanG § 2(4) |
MedCanG §§ 4 and 12; Arzneimittelgesetz (AMG) §§ 13, 52a and 72; KCanG §§ 2, 11 and 33; BLE consumer cannabis page; BfArM cultivation guidance (as of 11/2025).
What every BfArM license application must contain
| Item | What the law asks for |
|---|---|
| People | Names and addresses of the applicant and every responsible person, and of those entitled to represent a company |
| Good conduct | A certificate of good conduct for presentation to an authority, for the applicant and each responsible person |
| Expertise | Proof of each responsible person’s expertise, and statements on whether they can meet their duties at all times |
| Sites | The location of each site, if possible with the land-registry plot, street, house number, building and part of the building |
| Scope | Whether medical or medical-scientific cannabis, and which activities are to be licensed |
| Varieties | The kind of cannabis each activity covers; BfArM counts every flower variety as its own kind |
| Science | An explanation of the scientific purpose in the application |
MedCanG § 7(2); BfArM cultivation guidance, footnote 1.
Extra items BfArM asks growers to file
| Item | What BfArM’s cultivation notes ask for |
|---|---|
| Company | Completed application form and a current, complete commercial-register extract |
| Rooms | Room or site plans of the growing areas |
| Factory approvals | A manufacturing authorization under AMG § 13 and a GMP certificate from the state authority for the manufacturing tied to growing, such as drying |
| Process | A detailed description of the growing and manufacturing process |
| Propagation | How plants are propagated and raised, for example from seed or cuttings |
| Microbial reduction | Whether germ reduction is part of manufacturing and, if so, which method |
| Trade | A separate MedCanG trade license to import cuttings or trade flowers |
BfArM, Hinweise zur Beantragung einer Erlaubnis nach § 4 MedCanG zum Anbau (as of 11/2025).
Investors checking who may own a license holder or a club should jump to ownership rules.
The MedCanG License Types BfArM Issues, and the Club License It Does Not
One BfArM license can combine several activities, but it must state the sites, the activities allowed and the kinds of cannabis covered (MedCanG § 6). Trade comes in two scopes: domestic trade only, or foreign trade including domestic trade, and every single import or export also needs its own BfArM approval under the narcotics foreign-trade rules (MedCanG §§ 12 and 14). Pharmacies need no MedCanG license to make, buy or dispense on prescription, and commercial carriers moving cannabis between licensed parties are exempt; BfArM reads that exemption as ending where storage goes beyond what transport requires (MedCanG § 5; BfArM FAQ).
The expertise test depends on the activity. Making a medicinal product requires the expertise of a qualified person, the batch-release officer under the medicines law; scientific growing requires a university degree in biology, chemistry, pharmacy, medicine or veterinary medicine; other activities require completed wholesale and foreign trade merchant training plus at least one year of practical work in the medicines trade, though BfArM may accept other proof case by case (MedCanG § 7(4)) and its trader notes also accept a degree in biology, chemistry, pharmacy or medicine.
Importers list every flower variety with its full name, country of cultivation, grower and source, and prove that it was grown under state control for medical purposes, for example with a copy of the foreign cultivation license; BfArM does not ask importers to send GMP or GACP (good agricultural and collection practice) certificates. For imports from outside the EU and the European Economic Area (EEA), the medicines law separately requires an import authorization and, as a rule, a certificate from the producing country’s authority that the goods were made to EU or equivalent manufacturing standards, or one of the alternative German certificates the law allows (AMG §§ 72 and 72a).
Activities a BfArM license can cover, and the expertise each needs
| Activity | Responsible person must show | Extra approvals |
|---|---|---|
| Growing, including harvesting | Merchant training plus one year in the medicines trade, or the qualified-person standard where the product is a medicine | AMG § 13 authorization and GMP certificate for drying |
| Manufacturing a medicinal product | The qualified-person expertise under AMG § 15(1) | AMG § 13 manufacturing authorization |
| Domestic trade | Merchant training plus one year in the medicines trade, or other proof BfArM accepts | AMG § 52a wholesale authorization (or § 13 manufacturing authorization) for medicines wholesale |
| Foreign trade, including domestic trade | Merchant training plus one year in the medicines trade, or other proof BfArM accepts | BfArM approval per import or export; AMG § 72 for imports from outside the EU and EEA |
| Scientific growing, making or use | A university degree in biology, chemistry, pharmacy, medicine or veterinary medicine | None stated |
MedCanG §§ 4, 7(3), 12 and 14; AMG §§ 13, 52a and 72; BfArM cultivation guidance and BfArM trader guidance.
Cultivation clubs under the KCanG at a glance
| Rule | Limit |
|---|---|
| Legal form | Registered non-profit association or registered cooperative only |
| Members | At most 500, all 18 or older with a home or usual residence in Germany for at least six months; one club per person |
| Who grows | Members only; paid staff (except members in marginal part-time jobs) and non-members may do only tasks not directly tied to growing or passing on |
| Passing on | At most 25 g a day and 50 g a month per member aged 21 or older; for members aged 18 to 20, 25 g a day, 30 g a month and no more than 10% THC |
| License term | Seven years, renewable on application after at least five years |
| Transfer | The license cannot be transferred to anyone else |
KCanG § 11; KCanG §§ 1(13), 12, 14, 16, 17 and 19.
A MedCanG license has no fixed term in the Act, but BfArM may time-limit it or attach conditions where international drug treaties, EU law or the safety and control of the trade require it (MedCanG § 10). It may be revoked if it goes unused for two calendar years, a period BfArM can extend for a legitimate interest (MedCanG § 11).
State AMG authorizations run on their own clock: the state authority must decide a wholesale application within three months, a period that pauses while it waits for further information (AMG § 52a). In our view, preparing the BfArM file while the state authority reviews the AMG application saves months, because that file must include the AMG authorization.
BfArM License Fees in Euros, Charged per Variety and per Site
BfArM’s fees are set in section 15 of the health ministry’s special fee ordinance (BMGBGebV, annex). Most items are charged for each kind of cannabis and each site, and BfArM counts every variety as its own kind, so the strain list drives the bill. The tables cover BfArM fees only, not any fees for state AMG authorizations.
BfArM fees for a new MedCanG license
| Activity (per variety, per site) | Fee |
|---|---|
| Growing, including harvesting | €240 |
| Manufacturing (except intermediates processed straight away) | €480 |
| Manufacturing for diagnostic or analytical use only | €240 |
| Domestic trade | €590 (time-limited one-off license €295; at most €8,850 per site) |
| Foreign trade, including domestic trade | €1,040 (time-limited one-off license €520; at most €15,600 per site) |
| Scientific, analytical or non-commercial growing, making, buying, passing on, import or export | €190 each (buying capped at €4,425 per site) |
BMGBGebV, annex, section 15, items 1.1 to 1.2.6.
BfArM fees for changes, shipments and inspections
| Action | Fee |
|---|---|
| New license for added activities or varieties | The same fee as a new license |
| New license after a change of license holder | 50% of the new-license fee |
| New license after moving the site (not within one building) | 50% of the new-license fee |
| Amendment of a license, per change | €190 (€90 if scientific or non-commercial) |
| Extension of a time-limited license | 25% of the new-license fee |
| Import or export approval, per variety | €70 (€35 if scientific or non-commercial) |
| Site inspection by BfArM | €660 to €15,000 plus travel costs |
| Advisory meeting for an applicant | €500 to €5,000 |
| Security order under MedCanG § 21(2) | €150 |
BMGBGebV, annex, section 15, items 2 to 10.1.
Sample BfArM license fees (our arithmetic)
| Plan | BfArM license fees |
|---|---|
| Grow and harvest only, 6 varieties at one site | €1,440 (6 × €240) |
| Grow and manufacture 6 varieties at one site | €4,320 (6 × €240 + 6 × €480) |
| Import and trade 20 varieties from one site | €15,600 (20 × €1,040 = €20,800, capped at €15,600) |
| Each later import of those 20 varieties | €1,400 in approvals (20 × €70) |
Fees from BMGBGebV, annex, section 15, items 1.1.1, 1.1.2, 1.1.4, 1.1.4.2 and 6. Excludes state AMG authorization fees, BfArM inspection fees, build-out and staff. Ask BfArM whether drying also needs the manufacturing line (€480 per variety).
Budget against demand, not fees. Since July 29, 2026, cannabis flowers, unprocessed or in preparations, may no longer be prescribed at statutory health insurance expense, while standardized extracts and dronabinol or nabilone medicines may still be, for seriously ill patients after a six-month trial of an approved cannabis medicine (SGB V § 31(6); federal health ministry FAQ). A separate bill to require in-person contact with a doctor before flowers are prescribed and to end mail-order supply had its first Bundestag reading on December 18, 2025 (health ministry bill page); the consolidated MedCanG we read on October 9, 2026 lists only its June 2024 amendment. In our view, a flower-only plan carries more demand risk than one that includes extracts.
Five Steps From Empty Building to a BfArM-Licensed Grow
Based on MedCanG §§ 6 to 9 and BfArM’s cultivation notes, the path from an empty site to licensed cultivation runs in five steps:
- Set up the company and name a responsible person for each site who meets the expertise test; order certificates of good conduct addressed to BfArM for the management and each responsible person.
- Obtain the manufacturing authorization under AMG § 13 and the GMP certificate from the state authority for drying and any later processing steps.
- File with BfArM: the signed application letter by post, with attachments BfArM accepts by email: the form, register extract, room plans, process description, propagation method, any germ-reduction method and the variety list.
- Cure any defect within the deadline BfArM sets, because an uncured defect is a ground the law says must lead to refusal; BfArM then issues a license naming the site, the activities and the varieties, possibly with conditions or a time limit.
- Add a trade license if you will import cuttings or trade in flowers, then keep records from day one and file the first yearly report by January 31.
In our view, files stall on the GMP drying setup and the responsible person more often than on forms, so our cannabis licensing and application team plans both before the room plans are drawn.
Who Can Own a German Cannabis Business, and Why Clubs Stay Closed to Investors
The MedCanG’s refusal grounds include no nationality or residency test, though BfArM’s notes for manufacturers ask for a business address in Germany; the grounds turn on people and setup. Among other grounds, BfArM must refuse a license if no responsible person is ensured for the site, if that person lacks the expertise or cannot meet the duties at all times, or if facts raise doubts about the reliability of the responsible person, the applicant or those who represent or manage a company (MedCanG § 9).
Control changes are priced at the holder level. If the license holder itself changes, BfArM charges 50% of the new-license fee; in our reading, a share sale leaves the company as holder, but any change in its filed representatives or responsible person must be reported without delay (BMGBGebV item 2.2; MedCanG § 8). In our view, investors should map who will represent the company and who will be the responsible person before signing, because those are the people BfArM screens.
In our view, cultivation clubs are not investable. A club must be a registered non-profit association or a registered cooperative, a cooperative may not distribute profit to members, and only members may grow. A paid outside provider may be given only one kind of task that is not directly tied to growing or passing on cannabis, such as advice or cleaning (KCanG §§ 12 and 17; federal health ministry FAQ).
Unlicensed growing, import or trade of medical cannabis is a crime punishable by up to three years in prison or a fine, and three months to five years in particularly serious cases such as commercial dealing, and higher ranges for the gravest cases (MedCanG § 25).
Where German Cannabis Sites Can Go: Neighboring Towns, Club Buffers and Locked Rooms
Sites in the same or neighboring municipalities can share one BfArM license; a site farther away needs its own license and its own responsible person (BfArM FAQ; MedCanG § 9).
Security is set by outcome rather than by a checklist: medical cannabis must be protected from access by unauthorized people, and BfArM says locked containers or rooms, or similarly effective measures, are enough (BfArM medical cannabis FAQ). Where a holder’s protection falls short, BfArM may order specific measures (MedCanG § 21).
Club sites have fixed buffers. A club’s premises may not lie within 200 meters of the entrance to a school, children’s or youth facility or playground, or inside a private home, and must be fenced or otherwise secured; outdoor growing areas must be screened from view. A state authority may refuse a club whose growing areas share a building or sit right next to another club’s, and each state government may cap clubs at one per 6,000 residents in a district or city (KCanG §§ 12, 22, 23 and 30).
Our cannabis facility design work checks the drying-room layout, power and security plan before a German site is optioned.
German Records, BfArM Inspections, Fines and the Payer Shift
BfArM controls cultivation as the state agency the UN Single Convention requires, may enter business premises during normal hours, take samples and, to prevent urgent dangers, provisionally stop a holder’s trade and seal its stock (MedCanG §§ 17 to 19). BfArM’s inspection fee runs from €660 to €15,000 plus travel costs.
The yearly report to BfArM, due each January 31 for the past year, covers the quantity harvested with the growing area, the quantities used to make dronabinol, with the dronabinol produced, or preparations, with the THC they contain, and the stock at year end; a holder that did not trade still files a nil return (MedCanG § 16; BfArM reporting page). Importing or exporting without an approval, or breaking a license condition, can bring a fine of up to €30,000; faulty records or reports up to €10,000 (MedCanG § 27).
Our Germany cannabis compliance consulting review checks variety lists, records, reports and security against what BfArM can inspect, before an inspector does.
Clubs answer to their state authority instead: yearly quantity reports by January 31, documentation kept five years, regular on-site checks with sampling, and a license that can be revoked for repeated breaches (KCanG §§ 15, 26 and 27).
Correction to published guidance (October 9, 2026): a law-firm guide to German medical cannabis, last modified September 1, 2026, still says cultivation is done by companies selected in a Europe-wide tender and commissioned by the Cannabis Agency. The federal health ministry says a Europe-wide tender is no longer necessary and that growers may market and distribute their own harvest.
Two Ways to Start: A BfArM License Plan or a GMP Yield Review
Investors get a license plan before money moves: who represents the company and serves as responsible person, the AMG approvals, the variety list and a Germany cannabis business plan with BfArM fees, extract and flower demand, and the reimbursement change built in. Licensed growers get a GMP yield review: grams per square meter, batch release results, drying-room HVACD, records and the yearly BfArM report against what an inspector checks. We deliver both, on-site in Germany or remotely. Send your company chart or your room and batch data for a review, and we will tell you plainly if another firm suits you better.
Germany License, Club and Reimbursement Questions, Answered
Can I open a cannabis shop or dispensary in Germany?
No. Medical cannabis reaches patients only through pharmacies on prescription, and the KCanG creates no commercial store license. Licensed clubs may pass cannabis only to their own members, and BLE says current law gives it no way to license regional, time-limited cannabis model projects.
Who licenses medical cannabis companies in Germany?
BfArM, the Federal Institute for Drugs and Medical Devices, grants MedCanG licenses for growing, making, trading, importing and exporting. State authorities grant the AMG manufacturing, wholesale and import authorizations, and supervise doctors and pharmacies.
Does a foreign investor need German residency to hold a BfArM license?
No residency test appears in the MedCanG’s refusal grounds, though BfArM’s notes for manufacturers ask for a business address in Germany. BfArM screens the reliability of the applicant, the responsible person and those who represent or manage the company, and each responsible person must meet the expertise test.
How much does a BfArM license cost?
Fees are charged per variety and per site: €240 for growing, €480 for manufacturing, €590 for domestic trade and €1,040 for foreign trade, with caps of €8,850 and €15,600 per site for the two trade scopes. Each import or export approval costs €70 per variety.
Do German cannabis growers need GMP approval?
Yes, for drying and later steps. BfArM asks growers to file an AMG § 13 manufacturing authorization and a GMP certificate from the state authority for the manufacturing tied to growing, such as drying.
Can an investor own part of a cannabis club?
No. Clubs must be registered non-profit associations or registered cooperatives, cooperatives may not distribute profit, and only members may grow. A paid outside provider may take on only one kind of task not directly tied to growing or passing on cannabis.
Are cannabis flowers still covered by German health insurance?
No, not by statutory health insurance since July 29, 2026. Standardized extracts and dronabinol or nabilone medicines remain covered for seriously ill patients, after a six-month trial of an approved cannabis medicine and with insurer approval of the first prescription unless a specialist designated by the Federal Joint Committee prescribes. Doctors may still prescribe flowers on a private prescription, outside statutory insurance.
What does a licensed German grower report, and when?
Each January 31, the yearly report to BfArM covers the quantity harvested and growing area, the quantities used for dronabinol or preparations, and year-end stock, per site. Records of every receipt and dispatch per variety are kept three years.
Cultivation and Facility Builds Behind Our Germany Advice
These projects are outside Germany; we show them for the cultivation, extraction and facility design work behind our German advice, and each is on our projects page.
Hexo Corp.
Gatineau, Quebec, Canada
Bostica
Lynn, MA, United States
Leafline Labs
Cottage Grove, MN, United States
View All Projects
View all Catalyst BC Projects
Startup Cost and Grow-Room Reading for German Applicants
Cannabis Business Startup Commissioning Essential Steps and Best Practices
The journey from concept to operation is challenging and complex in the cannabis industry. One critical phase that determines the success of a cannabis business
The Psychrometrics of Cannabis Grow Rooms: Managing Latent Heat Load
In 2026, the global cannabis market has moved into a “Pharma-Grade” era. As of 2026, the leading cultivators are no longer just managing “temperature and
Cannabis Startup Costs: From Licensing to Profitability
Starting a legal cannabis business isn’t just about getting a license—it’s about building a profitable, compliant, and sustainable operation in one of the world’s most
Germany Sources: Federal Laws, BfArM, BMG and BLE
Provenance. Figures checked against the law and agency text by Catalyst BC on October 9, 2026. Federal laws and the fee ordinance were read in German on gesetze-im-internet.de, the federal justice ministry’s consolidated-law site; BfArM, BMG and BLE pages were read on the agencies’ own websites, and BfArM PDFs by text extraction. English wording on this page is our translation. Fee totals marked as our arithmetic are our own. Company figures come from Catalyst BC’s own records. Where this page and the official text differ, the official text governs.
Federal laws and ordinances
- Medizinal-Cannabisgesetz (MedCanG), consolidated
- Konsumcannabisgesetz (KCanG), consolidated
- Sozialgesetzbuch V, § 31 (medicines; cannabis reimbursement)
- Besondere Gebührenverordnung BMG (BMGBGebV), annex, section 15
- Arzneimittelgesetz (AMG), § 13 (manufacturing authorization)
- Arzneimittelgesetz (AMG), § 15 (qualified person expertise)
- Arzneimittelgesetz (AMG), § 52a (wholesale authorization)
- Arzneimittelgesetz (AMG), § 72 (import authorization)
- Arzneimittelgesetz (AMG), § 72a (import certificates)
BfArM, BMG and BLE
- BfArM, Medizinisches Cannabis
- BfArM, Erlaubnis
- BfArM, FAQ Medizinisches Cannabis
- BfArM, Meldungen nach § 16 Abs. 3 MedCanG
- BfArM, Hinweise zur Beantragung: Anbau (as of 11/2025)
- BfArM, Hinweise für Händler (as of 09/2025)
- BfArM, Hinweise für Hersteller (as of 04/2024)
- Federal Ministry of Health, FAQ on the Cannabis Act
- Federal Ministry of Health, bill to amend the MedCanG
- Federal Ministry of Health, FAQ on the MedCanG amendment
- BLE, Konsumcannabis
Contact Us
Enough about us. We want to hear more about you, your project, and your vision! Get in touch with a real live person today. Don’t worry, we don’t have a long, confusing phone menu, and your email isn’t going to the abyss, we promise. At Catalyst, we provide the service and support we’d want to experience ourselves!